Millipore Q1 revs up 14% on pharma spending
Millipore says that rebounding Big Pharma spending and biotechnology drove first-quarter 2010 gains.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Millipore says that rebounding Big Pharma spending and biotechnology drove first-quarter 2010 gains.